We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Soc Telemed Inc (TLMD) USD0.0001 A

Sell:$0.65 Buy:$0.65 Change: $0.0357 (5.77%)
Market closed |  Prices as at close on 25 January 2022 | Switch to live prices |
Change: $0.0357 (5.77%)
Market closed |  Prices as at close on 25 January 2022 | Switch to live prices |
Change: $0.0357 (5.77%)
Market closed |  Prices as at close on 25 January 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

SOC Telemed, Inc. is a provider of acute care telemedicine services and technology to United States hospitals and healthcare systems. The Company provides technology enabled clinical solutions, which include acute teleNeurology, telePsychiatry, and teleICU. The Company offers technology platform, Telemed IQ that allows hospitals, health systems and other healthcare organizations the ability to provide telemedicine programs either with their its clinical team or in conjunction with its affiliated network of established, board-certified physicians and other provider specialists. Its cloud based Telemed IQ technology platform is an integrated and configurable technology solution that seamlessly combines voice, video, imaging, electronic medical record (EMR) integration, clinical workflow optimization, clinical resource management, analytics, predictive modeling and other reporting tools.

Contact details

1768 Business Center Drive, Suite 100
United States
+1 (646) 9756581

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$71.47 million
Shares in issue:
100.84 million
Health Care Services
United States
US dollar

Key personnel

  • Christopher Gallagher
    Chief Executive Officer, Director
  • David Fletcher
    Interim Chief Financial Officer
  • David Mikula
    Chief Operating Officer
  • Sean Banerjee
    Chief Technology Officer
  • Eunice Kim
    General Counsel, Corporate Secretary
  • R. Jason Hallock
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.